Clinical trial
Extracellular RNAs in Relation to Cardiometabolic Risk
NCT03225196 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extracellular RNAs in Relation to Cardiometabolic Risk
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 17, 2017
- Completion date
- June 11, 2020
- Enrollment
- 4,495 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure, obesity, subclinical atherosclerotic cardiovascular disease